These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29061652)

  • 1. Progressive Renal Disease Established by Renin-Coding Adeno-Associated Virus-Driven Hypertension in Diverse Diabetic Models.
    Harlan SM; Heinz-Taheny KM; Sullivan JM; Wei T; Baker HE; Jaqua DL; Qi Z; Cramer MS; Shiyanova TL; Breyer MD; Heuer JG
    J Am Soc Nephrol; 2018 Feb; 29(2):477-491. PubMed ID: 29061652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of lisinopril and empagliflozin in a mouse model of hypertension-accelerated diabetic kidney disease.
    Østergaard MV; Secher T; Christensen M; Salinas CG; Roostalu U; Skytte JL; Rune I; Hansen HH; Jelsing J; Vrang N; Fink LN
    Am J Physiol Renal Physiol; 2021 Aug; 321(2):F149-F161. PubMed ID: 34180715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathological and Transcriptome Changes in the ReninAAV db/ db uNx Model of Advanced Diabetic Kidney Disease Exhibit Features of Human Disease.
    Harlan SM; Heinz-Taheny KM; Overstreet JM; Breyer MD; Harris RC; Heuer JG
    Toxicol Pathol; 2018 Dec; 46(8):991-998. PubMed ID: 30392455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of TGF-alpha in the progression of diabetic kidney disease.
    Heuer JG; Harlan SM; Yang DD; Jaqua DL; Boyles JS; Wilson JM; Heinz-Taheny KM; Sullivan JM; Wei T; Qian HR; Witcher DR; Breyer MD
    Am J Physiol Renal Physiol; 2017 Jun; 312(6):F951-F962. PubMed ID: 28249836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephroprotective Effects of Semaglutide as Mono- and Combination Treatment with Lisinopril in a Mouse Model of Hypertension-Accelerated Diabetic Kidney Disease.
    Dalbøge LS; Christensen M; Madsen MR; Secher T; Endlich N; Drenic' V; Manresa-Arraut A; Hansen HH; Rune I; Fink LN; Østergaard MV
    Biomedicines; 2022 Jul; 10(7):. PubMed ID: 35884965
    [No Abstract]   [Full Text] [Related]  

  • 6. The SGLT2 inhibitor empagliflozin ameliorates early features of diabetic nephropathy in BTBR ob/ob type 2 diabetic mice with and without hypertension.
    Gembardt F; Bartaun C; Jarzebska N; Mayoux E; Todorov VT; Hohenstein B; Hugo C
    Am J Physiol Renal Physiol; 2014 Aug; 307(3):F317-25. PubMed ID: 24944269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrative transcriptomic profiling of a mouse model of hypertension-accelerated diabetic kidney disease.
    Sembach FE; Ægidius HM; Fink LN; Secher T; Aarup A; Jelsing J; Vrang N; Feldt-Rasmussen B; Rigbolt KTG; Nielsen JC; Østergaard MV
    Dis Model Mech; 2021 Oct; 14(10):. PubMed ID: 34494644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Viral transduction of renin rapidly establishes persistent hypertension in diverse murine strains.
    Harlan SM; Ostroski RA; Coskun T; Yantis LD; Breyer MD; Heuer JG
    Am J Physiol Regul Integr Comp Physiol; 2015 Sep; 309(5):R467-74. PubMed ID: 26108870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel therapies for diabetic kidney disease.
    Alicic RZ; Tuttle KR
    Adv Chronic Kidney Dis; 2014 Mar; 21(2):121-33. PubMed ID: 24602462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human carnosinase 1 overexpression aggravates diabetes and renal impairment in BTBR
    Qiu J; Albrecht T; Zhang S; Hauske SJ; Rodriguez-Niño A; Zhang X; Nosan D; Pastene DO; Sticht C; Delatorre C; van Goor H; Porubsky S; Krämer BK; Yard BA
    J Mol Med (Berl); 2020 Sep; 98(9):1333-1346. PubMed ID: 32803273
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of diabetic nephropathy between male and female eNOS
    Ma Y; Li W; Yazdizadeh Shotorbani P; Dubansky BH; Huang L; Chaudhari S; Wu P; Wang LA; Ryou MG; Zhou Z; Ma R
    Am J Physiol Renal Physiol; 2019 May; 316(5):F889-F897. PubMed ID: 30810354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects.
    Eid SA; Hinder LM; Zhang H; Eksi R; Nair V; Eddy S; Eichinger F; Park M; Saha J; Berthier CC; Jagadish HV; Guan Y; Pennathur S; Hur J; Kretzler M; Feldman EL; Brosius FC
    FASEB J; 2021 May; 35(5):e21467. PubMed ID: 33788970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined effect of hyperfiltration and renin angiotensin system activation on development of chronic kidney disease in diabetic db/db mice.
    Hartono SP; Knudsen BE; Lerman LO; Textor SC; Grande JP
    BMC Nephrol; 2014 Apr; 15():58. PubMed ID: 24708836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Another patient with a natural history of diabetic nephropathy: current situation and means of prevention.
    Heras M; Saiz A; Sánchez R; Fernández-Reyes MJ; Molina A; Rodríguez MA
    Nefrologia; 2011; 31(1):108-10. PubMed ID: 21270923
    [No Abstract]   [Full Text] [Related]  

  • 16. Sustained Klotho delivery reduces serum phosphate in a model of diabetic nephropathy.
    Hum JM; O'Bryan LM; Tatiparthi AK; Clinkenbeard EL; Ni P; Cramer MS; Bhaskaran M; Johnson RL; Wilson JM; Smith RC; White KE
    J Appl Physiol (1985); 2019 Apr; 126(4):854-862. PubMed ID: 30605400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synopsis of Sweet! Mouse Models of Diabetic Kidney Disease.
    Heinz-Taheny KM; Harlan SM; Qi Z; Heuer JG
    Toxicol Pathol; 2018 Dec; 46(8):970-975. PubMed ID: 30213245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertension and renal complications in type 2 diabetes.
    Nosadini R
    Semin Vasc Med; 2002 Feb; 2(1):109-19. PubMed ID: 16222601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hyperglycemia and rosiglitazone on renal and urinary neprilysin in db/db diabetic mice.
    Alawi LF; Emberesh SE; Owuor BA; Chodavarapu H; Fadnavis R; El-Amouri SS; Elased KM
    Physiol Rep; 2020 Feb; 8(3):e14364. PubMed ID: 32026607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
    Liang G; Song L; Chen Z; Qian Y; Xie J; Zhao L; Lin Q; Zhu G; Tan Y; Li X; Mohammadi M; Huang Z
    Kidney Int; 2018 Jan; 93(1):95-109. PubMed ID: 28750927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.